
Precipio PRPO
$ 26.16
2.35%
Annual report 2025
added 03-30-2026
Precipio P/E Ratio 2011-2026 | PRPO
Annual P/E Ratio Precipio
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -106 | -8.16 | -1.49 | -0.0635 | -3.79 | -4.28 | -0.83 | -0.269 | -0.258 | -2.12 | -0.239 | -2.01 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.0635 | -106 | -10.8 |
P/E Ratio of other stocks in the Diagnostics research industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-10.3 | - | -6.23 % | $ 30.6 M | ||
|
Biodesix
BDSX
|
-2.14 | $ 15.79 | 4.78 % | $ 2.05 B | ||
|
Agilent Technologies
A
|
34.7 | $ 115.15 | -0.26 % | $ 35 B | ||
|
Biomerica
BMRA
|
-1.45 | $ 2.15 | -1.15 % | $ 4.94 M | ||
|
BioNano Genomics
BNGO
|
-0.301 | $ 1.16 | -3.75 % | $ 6.32 M | ||
|
Burning Rock Biotech Limited
BNR
|
-7.25 | $ 16.25 | 0.28 % | $ 175 M | ||
|
CareDx, Inc
CDNA
|
-46.5 | $ 18.22 | -0.49 % | $ 971 M | ||
|
Aspira Women's Health
AWH
|
-1.67 | - | -6.19 % | $ 10.5 M | ||
|
Co-Diagnostics
CODX
|
-0.125 | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
Biocept
BIOC
|
-0.185 | - | -13.05 % | $ 7.29 M | ||
|
Charles River Laboratories International
CRL
|
-53.3 | $ 167.39 | -3.74 % | $ 8.3 B | ||
|
Castle Biosciences
CSTL
|
38.9 | $ 25.23 | 1.57 % | $ 701 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.172 | - | - | $ 9.42 M | ||
|
Danaher Corporation
DHR
|
41.4 | $ 192.1 | 0.51 % | $ 137 B | ||
|
DexCom
DXCM
|
30.5 | $ 63.05 | 1.33 % | $ 24.6 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-233 | - | - | $ 562 M | ||
|
Fulgent Genetics
FLGT
|
-10.9 | $ 16.55 | -1.61 % | $ 500 M | ||
|
Akumin
AKU
|
-0.479 | - | -17.87 % | $ 25.9 M | ||
|
Guardant Health
GH
|
-32.3 | $ 90.82 | -3.21 % | $ 11.4 B | ||
|
Accelerate Diagnostics
AXDX
|
-2.76 | - | -61.36 % | $ 2.46 M | ||
|
ICON Public Limited Company
ICLR
|
21 | $ 111.31 | -2.52 % | $ 9.18 B | ||
|
Interpace Biosciences
IDXG
|
0.299 | $ 1.92 | -1.92 % | $ 8.49 M | ||
|
Illumina
ILMN
|
-13.4 | $ 127.58 | 0.15 % | $ 20.3 B | ||
|
IQVIA Holdings
IQV
|
20.8 | $ 170.35 | -1.67 % | $ 29.3 B | ||
|
Global Cord Blood Corporation
CO
|
0.485 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-9.08 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.29 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-3.07 | - | 0.12 % | $ 80.1 M | ||
|
Exact Sciences Corporation
EXAS
|
-93.8 | - | - | $ 19.8 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
39.9 | - | - | $ 10.7 B | ||
|
Laboratory Corporation of America Holdings
LH
|
27.3 | $ 274.41 | 0.22 % | $ 22.8 B | ||
|
Lantheus Holdings
LNTH
|
21.9 | $ 75.97 | -0.17 % | $ 5.13 B | ||
|
DermTech
DMTK
|
-0.421 | - | -11.32 % | $ 2.94 M | ||
|
Medpace Holdings
MEDP
|
28.7 | $ 495.2 | -0.63 % | $ 14.3 B | ||
|
Mettler-Toledo International
MTD
|
32.7 | $ 1 263.66 | 0.3 % | $ 26 B | ||
|
Myriad Genetics
MYGN
|
-1.12 | $ 4.79 | 0.74 % | $ 444 M | ||
|
ENDRA Life Sciences
NDRA
|
-0.521 | $ 4.56 | -2.72 % | $ 3.59 M | ||
|
NeoGenomics
NEO
|
-13.7 | $ 7.99 | -0.13 % | $ 1.02 B | ||
|
Neogen Corporation
NEOG
|
-0.933 | $ 9.49 | 0.8 % | $ 2.06 B | ||
|
Enzo Biochem
ENZ
|
-0.00221 | - | -8.98 % | $ 14.8 K | ||
|
National Research Corporation
NRC
|
27.2 | $ 17.52 | 2.07 % | $ 392 M | ||
|
Natera
NTRA
|
-9.69 | $ 205.75 | -1.07 % | $ 20.2 B | ||
|
Pacific Biosciences of California
PACB
|
-0.911 | $ 1.41 | 4.85 % | $ 423 M | ||
|
Koninklijke Philips N.V.
PHG
|
9.27 | $ 27.16 | 0.18 % | $ 20 B | ||
|
Personalis
PSNL
|
-3.12 | $ 6.62 | 0.53 % | $ 392 M | ||
|
RadNet
RDNT
|
-302 | $ 55.4 | 1.11 % | $ 4.17 B | ||
|
Heska Corporation
HSKA
|
-42.4 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.138 | - | -20.0 % | $ 1.06 M | ||
|
Senseonics Holdings
SENS
|
-5.07 | $ 6.93 | 0.36 % | $ 289 M |